Devices/Safety Alert·openFDA/device

MiniMed 780G US System BLE Connect 3.0 mg/dL (Medtronic Puerto Rico Operations Co.) — Malfunction

MediumPublished Aug 31, 2026· AI-analyzed Sep 9, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

A malfunction was reported involving the MiniMed 780G US System BLE Connect 3.0 mg/dL, manufactured by Medtronic Puerto Rico Operations Co. The source identifies the event strictly as a device malfunction without detailing specific patient injuries or clinical outcomes.

Who it affects

This report affects Medtronic Puerto Rico Operations Co. and regulatory/quality personnel responsible for insulin delivery systems and Bluetooth-enabled medical devices.

Why it matters

The reported malfunction in the Bluetooth Low Energy (BLE) connection component suggests potential issues with data synchronization or system integration between the pump and its peripheral components. While the source does not detail the failure mode, such malfunctions in automated insulin delivery systems can impact the reliability of real-time glucose monitoring and insulin dosing algorithms.

Practical takeaway

Quality and engineering teams should review the wireless connectivity and data transmission logs for the MiniMed 780G US System to identify failure modes related to the 'BLE Connect' function. Regulatory teams should assess if this malfunction requires supplemental reporting or updates to the risk management file regarding Bluetooth Low Energy stability.

FDA source material

Event type: Malfunction. Device: MiniMed 780G US System BLE Connect 3.0 mg/dL by Medtronic Puerto Rico Operations Co..

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.